BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 19074884)

  • 1. Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk.
    Cooper ML; Adami HO; Grönberg H; Wiklund F; Green FR; Rayman MP
    Cancer Res; 2008 Dec; 68(24):10171-7. PubMed ID: 19074884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survival.
    Penney KL; Li H; Mucci LA; Loda M; Sesso HD; Stampfer MJ; Ma J
    Prostate; 2013 May; 73(7):700-5. PubMed ID: 23129481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer.
    Chan JM; Oh WK; Xie W; Regan MM; Stampfer MJ; King IB; Abe M; Kantoff PW
    J Clin Oncol; 2009 Aug; 27(22):3577-83. PubMed ID: 19528373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations of SELENOF and SELENOP genotypes with serum selenium levels and prostate cancer.
    Ekoue DN; Ansong E; Liu L; Macias V; Deaton R; Lacher C; Picklo M; Nonn L; Gann PH; Kajdacsy-Balla A; Prins GS; Freeman VL; Diamond AM
    Prostate; 2018 Mar; 78(4):279-288. PubMed ID: 29314169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis.
    Xie W; Yang M; Chan J; Sun T; Mucci LA; Penney KL; Lee GS; Kantoff PW
    Prostate; 2016 May; 76(7):691-9. PubMed ID: 26847995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer.
    Abe M; Xie W; Regan MM; King IB; Stampfer MJ; Kantoff PW; Oh WK; Chan JM
    BJU Int; 2011 Jan; 107(1):126-34. PubMed ID: 20477822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk.
    Mikhak B; Hunter DJ; Spiegelman D; Platz EA; Wu K; Erdman JW; Giovannucci E
    Carcinogenesis; 2008 Dec; 29(12):2335-40. PubMed ID: 18784358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toenail selenium, plasma selenoprotein P and risk of advanced prostate cancer: A nested case-control study.
    Outzen M; Tjønneland A; Hughes DJ; Jenab M; Frederiksen K; Schomburg L; Morris S; Overvad K; Olsen A
    Int J Cancer; 2021 Feb; 148(4):876-883. PubMed ID: 32838475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between polymorphisms in glutathione peroxidase and selenoprotein P genes, glutathione peroxidase activity, HRT use and breast cancer risk.
    Méplan C; Dragsted LO; Ravn-Haren G; Tjønneland A; Vogel U; Hesketh J
    PLoS One; 2013; 8(9):e73316. PubMed ID: 24039907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence.
    Gerstenberger JP; Bauer SR; Van Blarigan EL; Sosa E; Song X; Witte JS; Carroll PR; Chan JM
    Prostate; 2015 Jan; 75(1):60-9. PubMed ID: 25284284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer.
    Li H; Kantoff PW; Giovannucci E; Leitzmann MF; Gaziano JM; Stampfer MJ; Ma J
    Cancer Res; 2005 Mar; 65(6):2498-504. PubMed ID: 15781667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study.
    Kang D; Lee KM; Park SK; Berndt SI; Peters U; Reding D; Chatterjee N; Welch R; Chanock S; Huang WY; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1581-6. PubMed ID: 17646272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in selenoprotein genes increase risk of colorectal cancer.
    Méplan C; Hughes DJ; Pardini B; Naccarati A; Soucek P; Vodickova L; Hlavatá I; Vrána D; Vodicka P; Hesketh JE
    Carcinogenesis; 2010 Jun; 31(6):1074-9. PubMed ID: 20378690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of NKX3.1 and SELENOP genotype with prostate cancer recurrence.
    Donadio JLS; Liu L; Freeman VL; Ekoue DN; Diamond AM; Bermano G
    Prostate; 2019 Apr; 79(5):462-467. PubMed ID: 30582190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men.
    Steinbrecher A; Méplan C; Hesketh J; Schomburg L; Endermann T; Jansen E; Akesson B; Rohrmann S; Linseisen J
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2958-68. PubMed ID: 20852007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival.
    Penney KL; Schumacher FR; Li H; Kraft P; Morris JS; Kurth T; Mucci LA; Hunter DJ; Kantoff PW; Stampfer MJ; Ma J
    Cancer Prev Res (Phila); 2010 May; 3(5):604-10. PubMed ID: 20424130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma.
    Peters U; Chatterjee N; Hayes RB; Schoen RE; Wang Y; Chanock SJ; Foster CB
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1144-54. PubMed ID: 18483336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival.
    Van Blarigan EL; Ma J; Kenfield SA; Stampfer MJ; Sesso HD; Giovannucci EL; Witte JS; Erdman JW; Chan JM; Penney KL
    Cancer Epidemiol Biomarkers Prev; 2014 Jun; 23(6):1037-46. PubMed ID: 24711484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations and interactions between variants in selenoprotein genes, selenoprotein levels and the development of abdominal aortic aneurysm, peripheral arterial disease, and heart failure.
    Strauss E; Tomczak J; Staniszewski R; Oszkinis G
    PLoS One; 2018; 13(9):e0203350. PubMed ID: 30188935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early-onset prostate cancer.
    Arsova-Sarafinovska Z; Matevska N; Petrovski D; Banev S; Dzikova S; Georgiev V; Sikole A; Sayal A; Aydin A; Suturkova L; Dimovski AJ
    Cell Biochem Funct; 2008 Oct; 26(7):771-7. PubMed ID: 18646267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.